CDSCO Panel Approves Updated Prescribing Information for AstraZeneca's Rosuvastatin (Crestor) Dr. Divya Colin8 Jun 2025 12:43 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval for the updated...
Sanofi launches 2025 Global Employee Stock Purchase Plan Ruchika Sharma8 Jun 2025 12:30 PM ISTParis: Sanofi's global employee shareholder plan, Action 2025, opens on June 10, 2025, to around 70,000 employees in 55 countries.In 2024 alone,...
Bayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor Ruchika Sharma8 Jun 2025 10:00 AM ISTSan Diego: Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of...
Lupin bags tentative nod from USFDA for partial-onset seizures drug Oxcarbazepine ER Ruchika Sharma7 Jun 2025 5:24 PM ISTMumbai: Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for...
Wockhardt seeks DCGI nod for Zaynich Ruchika Sharma7 Jun 2025 3:33 PM ISTDrugmaker Wockhardt on Friday said that it has filed for regulatory approval of its Zaynich with the Drug Controller General of India (DCGI),...
Reckitt names Ravi Bhatnagar as Director Corporate Communications and Corporate Affairs (South Asia, MENARP and Africa) Ruchika Sharma7 Jun 2025 2:38 PM ISTReckitt has appointed Ravi Bhatnagar as its new Director of Corporate Communications and Corporate Affairs for South Asia, MENARP, and...
Suspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad Ruchika Sharma6 Jun 2025 5:30 PM ISTTelangana: In a raid conducted at the residence of a habitual offender in Hyderabad, the Drugs Control Administration, Telangana has...
Zydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million Ruchika Sharma6 Jun 2025 3:05 PM ISTPennington: Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences Limited, has entered into Securities Purchase...
AstraZeneca Calquence based regimens approved in EU for previously untreated chronic lymphocytic leukaemia Ruchika Sharma6 Jun 2025 12:28 PM ISTA fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, has received...
Bristol Myers Squibb, BioNTech ink pact to co-develop, co-commercialize investigational bispecific antibody for multiple solid tumor types Ruchika Sharma6 Jun 2025 11:30 AM ISTPrinceton: BioNTech SE and Bristol Myers Squibb have announced that the companies have entered into an agreement for the global...
Panacea Biotec announces listing of EmulsiPan adjuvant in CEPI Adjuvant Library Ruchika Sharma6 Jun 2025 10:15 AM ISTPanacea Biotec Limited has announced the listing of EmulsiPan in the CEPI (Coalition for Epidemic Preparedness Innovations) Library of...
SEC Approves Serum's Salk Polio Vaccine for Commercial Use, Recommends Phase I Trial for 21-valent Pneumococcal Vaccine Parthika Patel5 Jun 2025 6:17 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Vaccines under the Central Drugs Standard Control Organization (CDSCO) has recommended the conduct of...
